Operating Expenses Summary of PetMed Express, Inc.

PetMed Express, Inc.'s latest annual operating expenses in 2024 was 86.81 Million USD , up 19.83% from previous year.
PetMed Express, Inc.'s latest quarterly operating expenses in 2024 FY was 78.55 Million USD , up 8.43% from previous quarter.
PetMed Express, Inc. reported a annual operating expenses of 72.44 Million USD in annual operating expenses 2023, up 38.34% from previous year.
PetMed Express, Inc. reported a annual operating expenses of 52.36 Million USD in annual operating expenses 2022, up 0.01% from previous year.
PetMed Express, Inc. reported a quarterly operating expenses of 19.18 Million USD for 2024 Q3, down -6.42% from previous quarter.
PetMed Express, Inc. reported a quarterly operating expenses of 24.65 Million USD for 2024 Q1, up 0.65% from previous quarter.

Annual Operating Expenses Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Operating Expenses of PetMed Express, Inc. (2024 - 2000)

Year	Operating Expenses	Operating Expenses Growth
2024	86.81 Million USD	19.83%
2023	72.44 Million USD	38.34%
2022	52.36 Million USD	0.01%
2021	52.36 Million USD	4.16%
2020	50.26 Million USD	2.3%
2019	49.14 Million USD	7.6%
2018	45.67 Million USD	9.18%
2017	41.83 Million USD	-4.73%
2016	43.9 Million USD	-6.47%
2015	46.94 Million USD	-4.97%
2014	49.39 Million USD	-1.43%
2013	50.11 Million USD	-7.44%
2012	54.14 Million USD	6.3%
2011	50.93 Million USD	-0.75%
2010	51.31 Million USD	0.38%
2009	51.12 Million USD	10.62%
2008	46.21 Million USD	7.32%
2007	43.06 Million USD	18.99%
2006	36.19 Million USD	16.17%
2005	31.15 Million USD	7.59%
2004	28.95 Million USD	44.98%
2003	19.97 Million USD	61.3%
2002	12.38 Million USD	97.26%
2001	6.27 Million USD	-12.82%
2000	7.2 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q4	20.21 Million USD	5.37%
2024 Q3	19.18 Million USD	-6.42%
2024 Q1	24.65 Million USD	0.65%
2024 Q2	20.5 Million USD	-16.84%
2024 FY	78.55 Million USD	8.43%
2023 Q1	16.45 Million USD	33.33%
2023 FY	72.44 Million USD	38.34%
2023 Q2	15.49 Million USD	-5.85%
2023 Q3	16 Million USD	3.34%
2023 Q4	24.49 Million USD	53.02%
2022 Q1	16.36 Million USD	34.82%
2022 FY	52.36 Million USD	0.01%
2022 Q2	11.08 Million USD	-32.24%
2022 Q4	12.34 Million USD	-1.89%
2022 Q3	12.57 Million USD	13.45%
2021 Q2	12.54 Million USD	-27.68%
2021 FY	52.36 Million USD	4.16%
2021 Q3	10.33 Million USD	-17.67%
2021 Q4	12.13 Million USD	17.47%
2021 Q1	17.34 Million USD	31.7%
2020 Q4	13.17 Million USD	34.9%
2020 Q3	9.76 Million USD	-16.04%
2020 Q1	15.7 Million USD	21.5%
2020 Q2	11.63 Million USD	-25.92%
2020 FY	50.26 Million USD	2.3%
2019 Q2	12.05 Million USD	-15.11%
2019 Q1	14.19 Million USD	30.07%
2019 FY	49.14 Million USD	7.6%
2019 Q4	12.92 Million USD	29.63%
2019 Q3	9.96 Million USD	-17.29%
2018 Q2	11.23 Million USD	-13.93%
2018 Q1	13.04 Million USD	24.78%
2018 Q4	10.91 Million USD	4.19%
2018 FY	45.67 Million USD	9.18%
2018 Q3	10.47 Million USD	-6.72%
2017 Q4	10.45 Million USD	16.36%
2017 Q2	10.33 Million USD	-14.26%
2017 Q1	12.05 Million USD	32.76%
2017 FY	41.83 Million USD	-4.73%
2017 Q3	8.98 Million USD	-13.02%
2016 Q4	9.07 Million USD	-0.59%
2016 FY	43.9 Million USD	-6.47%
2016 Q3	9.13 Million USD	-22.76%
2016 Q2	11.82 Million USD	-14.79%
2016 Q1	13.87 Million USD	52.14%
2015 Q1	15.93 Million USD	54.38%
2015 Q2	12.45 Million USD	-21.83%
2015 Q3	9.43 Million USD	-24.26%
2015 Q4	9.12 Million USD	-3.33%
2015 FY	46.94 Million USD	-4.97%
2014 FY	49.39 Million USD	-1.43%
2014 Q2	12.72 Million USD	-22.98%
2014 Q3	9.84 Million USD	-22.63%
2014 Q4	10.32 Million USD	4.87%
2014 Q1	16.51 Million USD	50.57%
2013 FY	50.11 Million USD	-7.44%
2013 Q4	10.96 Million USD	9.66%
2013 Q3	10 Million USD	-23.31%
2013 Q2	13.04 Million USD	-18.98%
2013 Q1	16.1 Million USD	26.85%
2012 Q4	12.69 Million USD	14.84%
2012 Q2	13.85 Million USD	-16.26%
2012 FY	54.14 Million USD	6.3%
2012 Q3	11.05 Million USD	-20.23%
2012 Q1	16.54 Million USD	49.96%
2011 Q4	11.03 Million USD	11.47%
2011 FY	50.93 Million USD	-0.75%
2011 Q3	9.89 Million USD	-32.22%
2011 Q1	15.39 Million USD	48.97%
2011 Q2	14.6 Million USD	-5.17%
2010 Q1	16.68 Million USD	58.1%
2010 Q2	13.85 Million USD	-17.0%
2010 FY	51.31 Million USD	0.38%
2010 Q3	10.44 Million USD	-24.6%
2010 Q4	10.33 Million USD	-1.02%
2009 Q1	16.02 Million USD	67.72%
2009 Q2	14.43 Million USD	-9.92%
2009 Q4	10.55 Million USD	4.46%
2009 FY	51.12 Million USD	10.62%
2009 Q3	10.1 Million USD	-30.02%
2008 Q4	9.55 Million USD	7.76%
2008 FY	46.21 Million USD	7.32%
2008 Q3	8.86 Million USD	-34.64%
2008 Q2	13.56 Million USD	-4.63%
2008 Q1	14.22 Million USD	56.2%
2007 FY	43.06 Million USD	18.99%
2007 Q4	9.1 Million USD	2.06%
2007 Q3	8.92 Million USD	-26.39%
2007 Q2	12.12 Million USD	-6.12%
2007 Q1	12.91 Million USD	75.44%
2006 Q4	7.36 Million USD	15.27%
2006 Q3	6.38 Million USD	-41.22%
2006 Q2	10.86 Million USD	-6.23%
2006 Q1	11.58 Million USD	94.77%
2006 FY	36.19 Million USD	16.17%
2005 Q2	8.75 Million USD	-21.37%
2005 Q1	11.13 Million USD	60.63%
2005 Q3	5.31 Million USD	-39.29%
2005 Q4	5.94 Million USD	11.89%
2005 FY	31.15 Million USD	7.59%
2004 Q2	7.29 Million USD	-24.47%
2004 FY	28.95 Million USD	44.98%
2004 Q3	5.07 Million USD	-30.44%
2004 Q1	9.65 Million USD	89.54%
2004 Q4	6.93 Million USD	36.63%
2003 FY	19.97 Million USD	61.3%
2003 Q1	4.97 Million USD	48.38%
2003 Q4	5.09 Million USD	26.89%
2003 Q2	5.89 Million USD	18.53%
2003 Q3	4.01 Million USD	-31.86%
2002 Q1	2.79 Million USD	14.51%
2002 Q4	3.35 Million USD	4.23%
2002 Q3	3.21 Million USD	6.25%
2002 Q2	3.02 Million USD	8.29%
2002 FY	12.38 Million USD	97.26%
2001 Q2	1.09 Million USD	-38.8%
2001 FY	6.27 Million USD	-12.82%
2001 Q1	1.79 Million USD	-12.46%
2001 Q3	945.34 Thousand USD	-13.93%
2001 Q4	2.43 Million USD	158.07%
2000 FY	7.2 Million USD	0.0%
2000 Q4	2.05 Million USD	0.0%

Peer Operating Expenses Comparison of PetMed Express, Inc.

Name	Operating Expenses	Operating Expenses Difference
CannBioRx Life Sciences Corp.	13.47 Million USD	-544.111%
BIMI International Medical Inc.	17.28 Million USD	-402.128%
China Jo-Jo Drugstores, Inc.	34.64 Million USD	-150.584%
Harrow Health, Inc. 8.625% Senior Notes due 2026	89.97 Million USD	3.515%
Harrow Health, Inc. 11.875% Senior Notes due 2027	90.12 Million USD	3.675%
Leafly Holdings, Inc.	44.5 Million USD	-95.07%
Leafly Holdings, Inc.	44.5 Million USD	-95.07%
LifeMD, Inc.	148.13 Million USD	41.398%
LifeMD, Inc.	148.13 Million USD	41.398%
TRxADE HEALTH, Inc.	9.86 Million USD	-780.277%
Walgreens Boots Alliance, Inc.	40.6 Billion USD	99.786%

Global Stocks Search

PetMed Express, Inc. (PETS)

Operating Expenses Summary of PetMed Express, Inc.

Annual Operating Expenses Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Operating Expenses of PetMed Express, Inc. (2024 - 2000)

Peer Operating Expenses Comparison of PetMed Express, Inc.